Clinical trial
Phase 1 Feasibility Trial of Inhaled Tobramycin in Preterm Infants With Bronchopulmonary Dysplasia
NCT04560179 is registered in ClinicalTrials.gov with Erik Allen Jensen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Feasibility Trial of Inhaled Tobramycin in Preterm Infants With Bronchopulmonary Dysplasia
- Lead sponsor
- Erik Allen Jensen
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 22, 2022
- Completion date
- May 17, 2024
- Enrollment
- 27 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.